Eric P. Rahrmann, Ph.D.
Affiliations: | 2011 | Molecular, Cellular, Developmental Biology and Genetics | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Genetics, Oncology, Human DevelopmentGoogle:
"Eric Rahrmann"Parents
Sign in to add mentor| David A. Largaespada | grad student | 2011 | UMN | |
| (Identification of novel genes involved in prostate and Schwann cell malignancies utilizing a Sleeping Beauty transposon somatic cell mutagenesis screen.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rahrmann EP, Shorthouse D, Jassim A, et al. (2022) The NALCN channel regulates metastasis and nonmalignant cell dissemination. Nature Genetics |
| Watson AL, Keller BJ, Williams KA, et al. (2020) Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. Oncotarget. 11: 3618-3620 |
| Smeester BA, Draper GM, Slipek NJ, et al. (2020) Implication of ZNF217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K-AKT signaling for the treatment of metastatic osteosarcoma. Molecular Cancer Therapeutics |
| Smeester BA, Slipek NJ, Pomeroy EJ, et al. (2020) PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma. Bone. 115353 |
| Smeester BA, Slipek NJ, Pomeroy EJ, et al. (2019) SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis. Oncogene |
| Beckmann PJ, Larson JD, Larsson AT, et al. (2019) Sleeping Beauty insertional mutagenesis reveals important genetic drivers of central nervous system embryonal tumors. Cancer Research |
| Rahrmann EP, Wolf NK, Otto GM, et al. (2018) Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma. Molecular Cancer Research : McR |
| Moriarity BS, Otto GM, Rahrmann EP, et al. (2015) A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. Nature Genetics. 47: 615-24 |
| Das P, Jackson P, Moriarity B, et al. (2015) PTPS-02FOXR2: AN ONCOGENE IN MEDULLOBLASTOMA Neuro-Oncology. 17: v179.2-v179 |
| Rathe SK, Moriarity BS, Stoltenberg CB, et al. (2014) Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia. Scientific Reports. 4: 6048 |